The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...
MSD/Merck & Co's headquarters in Rahway, New Jersey. MSD has said it plans to separate its cancer and non-cancer pharma operations as it prepares for the looming loss of patent protection for $31 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results